Key factors
sym | EYES |
exch | US |
MCap | 54.38M |
Beta | 2.557 |
EPS | -0.22 |
Div date | 0000-00-00 |
Yesterday
sym | EYES |
exch | US |
close | 4.14 |
50 Day MA | 5.834 |
200 Day MA | 5.130 |
Target Price | 2.5 |
Market Cap Mln | 54.38 |
Share statistics
Shares Outstanding | 13.13M |
Shares Float | 9377.68K |
Percent Institutions | 5.725 |
PercentInsiders | 28.61 |
SharesShort | 1082.86K |
Short Ratio | 5.21 |
Shares Short Prior Month | 1132.36K |
Short Percent | 3.849 |
Income
Revenue TTM | 497.0K |
Revenue Per Share TTM | 0.027 |
Quarterly Revenue Growth YOY | -71.8 |
Gross Profit TTM | 130.0K |
EBITDA | -9077.0K |
Diluted Eps TTM | -0.22 |
earning
Earnings Share | -0.22 |
Dividend
Dividend Date | 2020-01-06 |
Last Split Date | 2022-08-19 |
Last Split Factor | 1:3 |
business
Enterprise Value Ebitda | 0.202 |
Enterprise Value Revenue | 85.70 |
Book Value /share | 4.8 |
Price Book MRQ | 0.862 |
Price Sales TTM | 167.39 |
ReturnOnAssetsTTM | -0.08 |
ReturnOnEquityTTM | -0.13 |
Sector
Gic Group | Health Care Equipment & Services |
Gic Industry | Health Care Equipment & Supplies |
Gic Sector | Health Care |
Gic Sub Industry | Health Care Equipment |
Industry | Health Care Equipment & Supplies |
Sector | Healthcare |
Codes
ISIN | US81362J2096 |
CIK | 1266806 |
Code | EYES |
CUSIP | 81362J209 |
Employer Id Number | 02-0692322 |
CountryISO | US |
Currency Code | USD |
Currency Name | US Dollar |
Exchange | NASDAQ |
Currency Symbol | $ |
fund
Type | Common Stock |
UpdatedAt | 2022-10-23 |
is Delisted | 1 |
Delisted Date | 2022-08-30 |
Home Category | Domestic Primary |
info
Fiscal Year End | December |
Full Time Employees | 15.0 |
IPODate | 2014-11-19 |
International Domestic | Domestic |
MostRecent Quarter | 2022-06-30 |
Contact
Name | Second Sight Medical Products |
Address | 13170 Telfair Avenue, Sylmar, CA, United States, 91342 |
Country Name | USA |
Phone | 818 833 5000 |
Web URL | https://www.secondsight.com |
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.